Претраживање
Приказ резултата 1-10 од 20
Jy-xhe-053, a benzodiazepine ligand less efficacious at GABAA receptors containing alpha1 and alpha5 than alpha2 and alpha3 subunits
(Elsevier Science BV, Amsterdam, 2009)
RY-023, an inverse agonist at alpha5 GABAA receptors: the influence on spatial memory and spontaneous locomotor activity
(Elsevier Science BV, Amsterdam, 2008)
Moclobemide dosage regimen adjustment in depressive patients on carbamazepine co-therapy
(Elsevier Science BV, Amsterdam, 2009)
Effects of a novel inverse agonist selective for alpha5 GABAA receptors on spatial memory: comparison with the standard non-selective inverse agonist DMCM
(Elsevier Science BV, Amsterdam, 2008)
Efficacy and safety of combined therapy with moclobemide and valproic acid or carbamazepine in depressive patients
(Elsevier Science BV, Amsterdam, 2009)
The involvement of adenosine A1 receptors in the antinociceptive effects of carbamazepine and oxcarbazepine in a rat model of inflammatory hyperalgesia
(Elsevier Science BV, Amsterdam, 2004)
WYS-8, a novel ligand at GABAA receptors: a step forward to linking in vitro with in vivo selectivity?
(Elsevier Science BV, Amsterdam, 2009)
Relative contribution of the alpha2-, 3-and 5-containing GABAA receptors to benzodiazepine effects in the water maze
(Elsevier Science BV, Amsterdam, 2008)
Effect of topiramate on valproic acid clearance in adult patients with epilepsy: a population pharmacokinetic study
(Elsevier Science BV, Amsterdam, 2009)
Electrophysiological and behavioral profile of a GABAA alpha5 subtype-functionally selective negative modulator
(Elsevier Science BV, Amsterdam, 2007)